Quarry LP Has $2.80 Million Position in Abrdn Life Sciences Investors (NYSE:HQL)

Quarry LP reduced its holdings in Abrdn Life Sciences Investors (NYSE:HQL) by 9.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 185,514 shares of the company’s stock after selling 20,190 shares during the period. Abrdn Life Sciences Investors accounts for about 0.7% of Quarry LP’s portfolio, making the stock its 24th largest holding. Quarry LP owned about 0.68% of Abrdn Life Sciences Investors worth $2,798,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Future Financial Wealth Managment LLC bought a new position in shares of Abrdn Life Sciences Investors in the 3rd quarter valued at about $30,000. Ashton Thomas Securities LLC bought a new position in shares of Abrdn Life Sciences Investors in the 3rd quarter valued at about $148,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Abrdn Life Sciences Investors in the 1st quarter valued at about $143,000. Kapstone Financial Advisors LLC bought a new position in shares of Abrdn Life Sciences Investors in the 3rd quarter valued at about $177,000. Finally, Sanctuary Advisors LLC bought a new position in shares of Abrdn Life Sciences Investors in the 2nd quarter valued at about $154,000. 32.21% of the stock is currently owned by institutional investors and hedge funds.

Abrdn Life Sciences Investors Price Performance

Shares of HQL opened at $14.23 on Thursday. The firm has a 50-day moving average of $14.70 and a 200-day moving average of $14.68. Abrdn Life Sciences Investors has a one year low of $12.19 and a one year high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Thursday, November 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 14.05%. The ex-dividend date is Thursday, November 21st. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.